Synthesis of HIV Reverse Transcriptase Inhibitors
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current synthetic routes for HIV reverse transcriptase inhibitors are costly, laborious, and inefficient, requiring expensive raw materials and generating excessive waste.
Innovation Solution
A novel process for synthesizing 3-(substituted phenoxy)-1-[(5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl])-pyridin-2(1H)-one derivatives, which are effective HIV reverse transcriptase inhibitors, using a simplified and cost-effective method involving cyclization and coupling reactions in specific solvents and conditions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current synthetic routes are used for HIV reverse transcriptase inhibitors, then the inhibitors can be produced, but the production is costly and generates excessive waste
Solution Approach 1:
The synthesis is divided into modular stages: preparing substituted phenols, synthesizing triazole intermediates, and coupling them in a final step. This segmentation allows for better material utilization and reduced waste at each stage, while maintaining reliable production of the inhibitors.
Solution Approach 2:
The patent employs specific solvent systems (aqueous alcohol mixtures), controlled temperature ranges (reflux conditions), and pH adjustments during synthesis. These parameter optimizations improve reaction efficiency and reduce material waste, while ensuring consistent production of high-quality HIV reverse transcriptase inhibitors.
2Reliability
If current synthetic routes are used for HIV reverse transcriptase inhibitors, then the inhibitors can be produced, but the process is laborious and inefficient
Solution Approach 1:
The patent prepares substituted phenols and triazole intermediates as pre-synthesized components with defined structures. This preliminary preparation simplifies the final coupling step and accelerates overall production, making the process more efficient while maintaining reliable inhibitor synthesis.
Solution Approach 2:
The synthesis employs continuous reflux conditions and one-pot coupling reactions where intermediates are directly transformed without extensive isolation steps. This continuous action reduces labor requirements and improves productivity while ensuring reliable production of the inhibitors.
3Reliability
If current synthetic routes are used for HIV reverse transcriptase inhibitors, then the inhibitors can be produced, but expensive raw materials are required
Solution Approach 1:
The patent uses readily available, low-cost starting materials such as substituted phenols and simple triazole precursors. These inexpensive reagents are transformed through efficient reactions to produce the inhibitors, reducing material costs while maintaining reliable production.
Solution Approach 2:
The synthesis employs aqueous alcohol solvent systems and controlled temperature conditions that improve reaction yields and reduce material consumption. These parameter optimizations lower the quantity of expensive raw materials needed while ensuring reliable inhibitor production.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The process provides a reliable and efficient synthesis of HIV reverse transcriptase inhibitors, reducing costs and waste while improving the ease of execution, effectively inhibiting HIV replication and treating HIV infections.
Implementation Method 1
reacting a compound of Formula E with a nitrogen source having formula NH3+nXn, wherein Xn = a non-coordinating counteranion and n = 0 or 1, at a first elevated temperature in a mixture of alcohol and organic solvent to make the compound of Formula F
Implementation Method 2
coupling the compound of Formula F with a compound of Formula A
Data Source
Figure 1
AI summary
The present invention is directed to a novel process for synthesizing 3-(substituted phenoxy)-1-[(5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl])-pyridin-2(1H)-one derivatives. The compounds synthesized by the processes of the invention are HIV reverse transcriptase inhibitors useful for inhibiting reverse transcriptase and HIV replication, and the treatment of human immunodeficiency virus infection in humans.